Symposia

Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance with Targeted Agents

Session Chair(s)

• 

  Elena Elez, Sr., MD PhD

  Vall Hebron University Hospital
  Barcelona, Spain
• 

  Yelena Janjigian, MD

  Memorial Sloan Kettering Cancer Center
  New York, United States

Educational activity provided by PeerView Live and supported by Daiichi Sankyo, Inc.

Presentations:

• 13:40 – 13:55

  Welcome and Pre-Seminar Prep: Setting Standards for HER2-Positive GI Cancers
  

  Session Chair: Elena Elez, Sr., MD PhD – Vall Hebron University Hospital
• 13:55 – 14:25

  Personalizing Care for HER2-Positive Gastric/GEJ Cancers Based on New Evidence
  

  Session Speaker: Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center
• 14:25 – 14:55

  The Present and Future of HER2-Targeted Therapy in Colorectal and Other GI Cancers
  

  Session Speaker: Elena Elez, Sr., MD PhD – Vall Hebron University Hospital
• 14:55 – 15:10

  Symposium Summary and Audience Q&A
  

  Session Chair: Elena Elez, Sr., MD PhD – Vall Hebron University Hospital

  Session Chair: Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center